brichnyc, I just read all your subsequent posts on Bishop and I would like to give you my 2 cents worth. I have been a subscriber for many years and Tom has made more than a few good calls in the medical field over the years including this year and, in particular, in the last week. While he may not have the credentials you personally are looking for it does not at all mean he does not do his homework or is not qualified to give an educated opinion. Also, to the best of my knowledge he does not "flip" stocks or short them. That is not what his newsletter advises. He plays in the small cap Russell type of arena. What I have learned is that he has limited time to research stocks. He probably does not have the time to do as thorough a job at dd as many have on the board. Basically, what he did for me was to introduce me to Anavex and then I dug much deeper into the dd than I am sure he did. However, based on the current participation level of analysts, why would we not put value on someone who has been able to contribute on the CC's? The science proving out will eventually bring out additional analysts anyway. No worries. GL
Market Data 
Markets 
AI
